Product Description: Deruxtecan-Eribulin is a Drug-Linker Conjugates for ADC, which is composed of a linker and a toxic molecule Exatecan (HY-13631) (DNA topoisomerase I inhibitor) and Eribulin (HY-13442) (Microtubule inhibitor). Deruxtecan-Eribulin can be used for ADC synthesis.
Applications: Cancer-programmed cell death
Formula: C122H151FN16O32
Molecular Weight: 2372.59
Research Area: Cancer
Target: Drug-Linker Conjugates for ADC;Microtubule/Tubulin;Topoisomerase